PODXL and colorectal cancer: Elevated expression of PODXL is significantly correlated with poor disease-free survival, cancer-specific survival, and overall survival in colorectal cancer, PDAC, renal cell carcinoma, urothelial bladder cancer, and glioblastoma multiforme [12].